SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Speciality Chemicals jumps on getting NCLT’s approval for composite scheme of arrangement

17 Apr 2017 Evaluate

Omkar Speciality Chemicals is currently trading at Rs. 180.35, up by 4.95 points or 2.82 % from its previous closing of Rs. 175.40 on the BSE.

The scrip opened at Rs. 176.00 and has touched a high and low of Rs. 181.90 and Rs. 176.00 respectively. So far 38412 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 194.60 on 18-Apr-2016 and a 52 week low of Rs. 130.05 on 09-Nov-2016.

Last one week high and low of the scrip stood at Rs. 183.20 and Rs. 156.00 respectively. The current market cap of the company is Rs. 371.74 crore.

The promoters holding in the company stood at 47.53%, while Institutions and Non-Institutions held 4.40% and 48.08% respectively.

Omkar Speciality Chemicals has received approval from the National Company Law Tribunal (NCLT) for the scheme of arrangement between Omkar Speciality Chemicals and Lasa Laboratory, Urdhwa Chemicals, Rishichem Research, Desh Chemicals and Lasa Supergenerics.

Accordingly, Lasa Laboratory, Urdhwa Chemicals, Rishichem Research, and Desh Chemicals will be merged with Omkar Speciality; along with the demerger of the veterinary API undertaking of the merged Omkar Speciality Chemicals into Lasa Supergenerics.

Omkar Speciality Chemicals is one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates.

Omkar SpecialityChem Share Price

4.30 0.10 (2.38%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×